Prulifloxacin oral solid composition and preparation method thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- SICHUAN KELUN PHARMA CO LTD
- Publication Date
- 2013-01-30
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to a pharmaceutical composition and a preparation method thereof, in particular to a prulifloxacin oral solid preparation and a preparation method thereof. Background technique
[0002] Prulifloxacin (PUFX) is a fourth-generation fluoroquinolone antibacterial drug and a prodrug of the metabolically active substance UFX (codenamed NM394). Nippon Shinyaku (Co., Ltd.) was the first to develop and enter preclinical research, and then Meiji Seika (Co., Ltd.) joined in preclinical and clinical joint research; and Japan Shinyaku (Co., Ltd.) cooperated with Shiquan Chemical Co., Ltd. Carry out research on its raw materials.
[0003] After oral administration, prulifloxacin is mainly absorbed by the small intestine, and 5-methyl-2-oxo-1,3-dioxole-4 at the C7 position is removed under the action of dioxygenase in the portal vein and liver - group, became NM394 (AF3013) with antibacterial activity. It has a wide antibacterial spectrum and...